BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2165 related articles for article (PubMed ID: 16818862)

  • 1. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.
    Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH
    Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal correlates of brain-derived neurotrophic factor Val66Met polymorphism and morphometric abnormalities in bipolar disorder.
    Matsuo K; Walss-Bass C; Nery FG; Nicoletti MA; Hatch JP; Frey BN; Monkul ES; Zunta-Soares GB; Bowden CL; Escamilla MA; Soares JC
    Neuropsychopharmacology; 2009 Jul; 34(8):1904-13. PubMed ID: 19295510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of brain-derived neurotrophic factor Val66Met polymorphism on hippocampal volume change in schizophrenia.
    Koolschijn PC; van Haren NE; Bakker SC; Hoogendoorn ML; Hulshoff Pol HE; Kahn RS
    Hippocampus; 2010 Sep; 20(9):1010-7. PubMed ID: 19714565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly.
    Miyajima F; Ollier W; Mayes A; Jackson A; Thacker N; Rabbitt P; Pendleton N; Horan M; Payton A
    Genes Brain Behav; 2008 Jun; 7(4):411-7. PubMed ID: 17973920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hippocampal volume and the brain-derived neurotrophic factor Val66Met polymorphism in first episode psychosis.
    Smith GN; Thornton AE; Lang DJ; Macewan GW; Ehmann TS; Kopala LC; Tee K; Shiau G; Voineskos AN; Kennedy JL; Honer WG
    Schizophr Res; 2012 Feb; 134(2-3):253-9. PubMed ID: 22192502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia.
    Ho BC; Andreasen NC; Dawson JD; Wassink TH
    Am J Psychiatry; 2007 Dec; 164(12):1890-9. PubMed ID: 18056245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety.
    Gatt JM; Nemeroff CB; Dobson-Stone C; Paul RH; Bryant RA; Schofield PR; Gordon E; Kemp AH; Williams LM
    Mol Psychiatry; 2009 Jul; 14(7):681-95. PubMed ID: 19153574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.
    Rybakowski JK; Borkowska A; Skibinska M; Szczepankiewicz A; Kapelski P; Leszczynska-Rodziewicz A; Czerski PM; Hauser J
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):70-6. PubMed ID: 16472361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain-derived neurotrophic factor (BDNF) Val(66)Met polymorphism differentially predicts hippocampal function in medication-free patients with schizophrenia.
    Eisenberg DP; Ianni AM; Wei SM; Kohn PD; Kolachana B; Apud J; Weinberger DR; Berman KF
    Mol Psychiatry; 2013 Jun; 18(6):713-20. PubMed ID: 23319002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the brain-derived neurotrophic factor Val66Met polymorphism and brain morphology in a Japanese sample of schizophrenia and healthy comparisons.
    Takahashi T; Suzuki M; Tsunoda M; Kawamura Y; Takahashi N; Tsuneki H; Kawasaki Y; Zhou SY; Kobayashi S; Sasaoka T; Seto H; Kurachi M; Ozaki N
    Neurosci Lett; 2008 Apr; 435(1):34-9. PubMed ID: 18325670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls.
    Zhang XY; Chen DC; Xiu MH; Haile CN; Luo X; Xu K; Zhang HP; Zuo L; Zhang Z; Zhang X; Kosten TA; Kosten TR
    Hum Genet; 2012 Jul; 131(7):1187-95. PubMed ID: 22362486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disturbances in selective information processing associated with the BDNF Val66Met polymorphism: evidence from cognition, the P300 and fronto-hippocampal systems.
    Schofield PR; Williams LM; Paul RH; Gatt JM; Brown K; Luty A; Cooper N; Grieve S; Dobson-Stone C; Morris C; Kuan SA; Gordon E
    Biol Psychol; 2009 Feb; 80(2):176-88. PubMed ID: 18838100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BDNF val66met modulates the association between childhood trauma, cognitive and brain abnormalities in psychoses.
    Aas M; Haukvik UK; Djurovic S; Bergmann Ø; Athanasiu L; Tesli MS; Hellvin T; Steen NE; Agartz I; Lorentzen S; Sundet K; Andreassen OA; Melle I
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():181-8. PubMed ID: 23876786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of the Met allele of the brain-derived neurotrophic factor Val66Met polymorphism to memory after aneurysmal subarachnoid hemorrhage.
    Vilkki J; Lappalainen J; Juvela S; Kanarek K; Hernesniemi JA; Siironen J
    Neurosurgery; 2008 Aug; 63(2):198-203; discussion 203. PubMed ID: 18797348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression.
    Frodl T; Schüle C; Schmitt G; Born C; Baghai T; Zill P; Bottlender R; Rupprecht R; Bondy B; Reiser M; Möller HJ; Meisenzahl EM
    Arch Gen Psychiatry; 2007 Apr; 64(4):410-6. PubMed ID: 17404118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BDNF Val66Met Polymorphism Interacts with Sleep Consolidation to Predict Ability to Create New Declarative Memories.
    Gosselin N; De Beaumont L; Gagnon K; Baril AA; Mongrain V; Blais H; Montplaisir J; Gagnon JF; Pelleieux S; Poirier J; Carrier J
    J Neurosci; 2016 Aug; 36(32):8390-8. PubMed ID: 27511011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor.
    Zivadinov R; Weinstock-Guttman B; Benedict R; Tamaño-Blanco M; Hussein S; Abdelrahman N; Durfee J; Ramanathan M
    Hum Mol Genet; 2007 Nov; 16(22):2659-68. PubMed ID: 17656372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the brain-derived neurotrophic factor val66met polymorphism with magnetic resonance spectroscopic markers in the human hippocampus: in vivo evidence for effects on the glutamate system.
    Gruber O; Hasan A; Scherk H; Wobrock T; Schneider-Axmann T; Ekawardhani S; Schmitt A; Backens M; Reith W; Meyer J; Falkai P
    Eur Arch Psychiatry Clin Neurosci; 2012 Feb; 262(1):23-31. PubMed ID: 21509595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain-derived neurotrophic factor gene Val66Met polymorphism and cognitive function in obsessive-compulsive disorder.
    Tükel R; Gürvit H; Ozata B; Oztürk N; Ertekin BA; Ertekin E; Baran B; Kalem SA; Büyükgök D; Direskeneli GS
    Am J Med Genet B Neuropsychiatr Genet; 2012 Oct; 159B(7):850-8. PubMed ID: 22911909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of BDNF Val66Met polymorphism on brain function in controls and patients with multiple sclerosis: an imaging genetic study.
    Cerasa A; Tongiorgi E; Fera F; Gioia MC; Valentino P; Liguori M; Manna I; Zito G; Passamonti L; Nisticò R; Quattrone A
    Behav Brain Res; 2010 Mar; 207(2):377-86. PubMed ID: 19874854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 109.